In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
A growing share of American homeowners now carry mortgage rates above 5%—a dramatic shift that’s reshaping refinancing, inventory, and buyer behavior nationwide. With more than 30% of borrowers locked into rates over 5% and 20% above 6%, the market is split between owners holding on to low pandemic‑era loans and new buyers taking on higher‑rate mortgages. Federal efforts to push rates down could unlock millions of refinancing opportunities, while buyers see only modest monthly savings. For real estate professionals, understanding these rate dynamics is crucial as they increasingly drive inventory levels, affordability, and market activity.
New Moody’s data shows commercial real estate deal volume slipped 20% in December, marking a second monthly decline. Yet the full year tells a different story: 2025 ended with a 17% gain, signaling a quiet but resilient recovery. The biggest surprise came from the office sector, which posted a 21% jump in activity as return‑to‑office trends and AI‑driven job growth boosted demand. Multifamily, retail, and alternative assets like data centers also saw strong momentum, giving real estate professionals a market full of fresh opportunities heading into 2026.
Florida drivers and industry professionals are heading into 2026 with good news: auto insurance rates are dropping across the state as the market shows strong signs of stabilization. USAA leads the latest wave with a 7% average rate decrease expected in May 2026, saving members more than $125 million annually. They join several major insurers — including State Farm, Progressive, AAA, Allstate, and Florida Farm Bureau — all approving significant reductions. Officials credit recent legislative reforms, especially tort reform, for the improved loss ratios and renewed insurer confidence. With both auto and home insurance markets strengthening, Florida’s real estate, mortgage, and insurance professionals can expect more consumer confidence, smoother transactions, and expanding career opportunities.
New data from Eye On Housing and the NAHB shows the U.S. remains short more than 1.2 million housing units, keeping pressure on both rents and home prices. Record‑low vacancy rates, slow single‑family construction, and restrictive zoning continue to fuel intense competition in 2024. Major metros like Chicago, New York, and Atlanta face some of the deepest deficits, and the true nationwide shortfall may be even higher when accounting for overcrowding and aging homes. For real estate professionals, the ongoing shortage means sustained demand, tighter inventory, and major opportunities for those who understand the evolving market.
Top real estate coach Jason Pantana says the divide between agents today isn’t about who has “tried” AI — it’s about who is immersed in it. In a new HousingWire interview, he explains why AI isn’t a gimmick but a full business system that amplifies output, improves authenticity, and reshapes how clients search for agents. From prompt mastery to AI‑driven visibility on Google, Pantana reveals how agents who commit even 15 minutes a day to learning AI are already outperforming those who hesitate.
Dallas–Fort Worth’s commercial real estate market closed 2025 with a split personality. Industrial dominated with massive new deliveries and soaring leasing demand, retail held steady with some of the market’s strongest fundamentals in years, and office continued to falter under remote‑work pressures. High vacancies, weak absorption, and rising demand for top‑tier space show the sector’s ongoing reset. Meanwhile, industrial and retail strength position the Metroplex for another powerhouse year heading into 2026.
